Search Results - "Pietri, Elisabetta"

Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer by DELLAPASQUA, Silvia, BERTOLINI, Francesco, PIETRI, Elisabetta, COLLEONI, Marco, BAGNARDI, Vincenzo, CAMPAGNOLI, Elisabetta, SCARANO, Eloise, TORRISI, Rosalba, SHAKED, Yuval, MANCUSO, Patrizia, GOLDHIRSCH, Aron, ROCCA, Andrea

“…Metronomic chemotherapy has shown efficacy in patients with metastatic breast cancer. When used in association with targeted antiangiogenic drugs, it was more…”
Get full text

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors by Farolfi, Alberto, Melegari, Elisabetta, Aquilina, Michele, Scarpi, Emanuela, Ibrahim, Toni, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, Ferrario, Cristiano, Fedeli, Anna, Faedi, Marina, Nanni, Oriana, Frassineti, Giovanni Luca, Amadori, Dino, Rocca, Andrea

“…Although adjuvant trastuzumab improves survival in patients with HER2-positive early breast cancer, there is growing concern about the long-term effect of…”
Get more information

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? by Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Puccetti, Maurizio, Tumedei, Maria Maddalena, Scarpi, Emanuela, Andreis, Daniele, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Fedeli, Anna, Pietri, Elisabetta, De Simone, Valeria, Asioli, Silvia, Amadori, Dino, Bravaccini, Sara

“…Androgen receptor (AR) is widely expressed in breast cancer (BC) but its role in estrogen receptor (ER)-positive tumors is still controversial. The AR/ER ratio…”
Get full text

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? by Bronte, Giuseppe, Bravaccini, Sara, Ravaioli, Sara, Puccetti, Maurizio, Scarpi, Emanuela, Andreis, Daniele, Tumedei, Maria Maddalena, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, De Simone, Valeria, Maltoni, Roberta, Bonafè, Massimiliano, Amadori, Dino, Rocca, Andrea

“…Genomic studies have shown that the androgen receptor (AR) pathway plays an important role in some breast cancer subtypes. However few data are present on the…”
Get full text

Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report by Mazzaschi, Giulia, Tommasi, Chiara, Pietri, Elisabetta, Corcione, Luigi, De Giorgi, Annamaria, Bini, Paola, Bui, Simona

“…A 66‐year‐old man with hypopharyngeal carcinoma with a single bone metastasis was treated with definitive chemo/radiotherapy omitting local treatment of the…”
Get full text

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer by Orlando, Laura, Cardillo, Anna, Ghisini, Raffaella, Rocca, Andrea, Balduzzi, Alessandra, Torrisi, Rosalba, Peruzzotti, Giulia, Goldhirsch, Aron, Pietri, Elisabetta, Colleoni, Marco

“…HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with…”
Get full text

The implication of liquid biopsies to predict chemoresistance in pancreatic cancer by Pietri, Elisabetta, Balsano, Rita, Coriano, Matilde, Gelsomino, Fabio, Leonardi, Francesco, Bui, Simona, Gnetti, Letizia, Valle, Raffaele Dalla, Garajová, Ingrid

“…Pancreatic cancer is one of the most aggressive diseases among solid tumors. Most patients are diagnosed with advanced or metastatic disease and are…”
Get full text

Perioperative Serum VEGF and Extracellular Domains of EGFR and HER2 in Early Breast Cancer by Rocca, Andrea, Cancello, Giuseppe, Bagnardi, Vincenzo, Sandri, Maria Teresa, Torrisi, Rosalba, Zorzino, Laura, Viale, Giuseppe, Pietri, Elisabetta, Veronesi, Paolo, Dellapasqua, Silvia, Ferrucci, Francesco, Luini, Alberto, Johansson, Harriet, Ghisini, Raffaella, Goldhirsch, Aron, Colleoni, Marco

“…Background: The prognostic role of serum levels of molecular biomarkers during the perioperative period in patients with early breast cancer is not clear…”
Get full text

Androgen receptor signaling pathways as a target for breast cancer treatment by Pietri, Elisabetta, Conteduca, Vincenza, Andreis, Daniele, Massa, Ilaria, Melegari, Elisabetta, Sarti, Samanta, Cecconetto, Lorenzo, Schirone, Alessio, Bravaccini, Sara, Serra, Patrizia, Fedeli, Anna, Maltoni, Roberta, Amadori, Dino, De Giorgi, Ugo, Rocca, Andrea

“…The androgen receptor (AR) is a ligand-dependent transcription factor, and its effects on breast range from physiological pubertal development and age-related…”
Get full text

P-92 GPS as a prognostic index and a predictor of toxicity in early or locally advanced head and neck cancer patients treated with radiotherapy or definitive chemoradiotherapy by Bui, Simona, Pietri, Elisabetta, de Corianò, Matil, Luca, Isella, Mazzaschi, Giulia, Tommasi, Chiara, Garajovà, Ingrid, Grondelli, Claudia

Get full text

Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte by Campi, Beatrice, Frascarelli, Sabina, Pietri, Elisabetta, Massa, Ilaria, Donati, Caterina, Bozic, Roberto, Bertelloni, Silvano, Paolicchi, Aldo, Zucchi, Riccardo, Saba, Alessandro

“…In the clinical laboratories, dehydroepiandrostenedione (DHEA) is usually quantified by immunoassay-based methods, which are often affected by cross-reactivity…”
Get full text

Uncovering the genomic heterogeneity of multifocal breast cancer by Desmedt, Christine, Fumagalli, Debora, Pietri, Elisabetta, Zoppoli, Gabriele, Brown, David, Nik-Zainal, Serena, Gundem, Gunes, Rothé, Françoise, Majjaj, Samira, Garuti, Anna, Carminati, Enrico, Loi, Sherene, Van Brussel, Thomas, Boeckx, Bram, Maetens, Marion, Mudie, Laura, Vincent, Delphine, Kheddoumi, Naima, Serra, Luigi, Massa, Ilaria, Ballestrero, Alberto, Amadori, Dino, Salgado, Roberto, de Wind, Alexandre, Lambrechts, Diether, Piccart, Martine, Larsimont, Denis, Campbell, Peter J, Sotiriou, Christos

“…Multifocal breast cancer (MFBC), defined as multiple synchronous unilateral lesions of invasive breast cancer, is relatively frequent and has been associated…”
Get full text

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer by Pietri, Elisabetta, Massa, Ilaria, Bravaccini, Sara, Ravaioli, Sara, Tumedei, Maria Maddalena, Petracci, Elisabetta, Donati, Caterina, Schirone, Alessio, Piacentini, Federico, Gianni, Lorenzo, Nicolini, Mario, Campadelli, Enrico, Gennari, Alessandra, Saba, Alessandro, Campi, Beatrice, Valmorri, Linda, Andreis, Daniele, Fabbri, Francesco, Amadori, Dino, Rocca, Andrea

“…Lessons Learned The androgen receptor (AR) is present in most breast cancers (BC), but its exploitation as a therapeutic target has been limited. This study…”
Get full text

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy by Ravaioli, Sara, Tumedei, Maria Maddalena, Foca, Flavia, Maltoni, Roberta, Rocca, Andrea, Massa, Ilaria, Pietri, Elisabetta, Bravaccini, Sara

“…Summary Ductal carcinoma in situ (DCIS) is a heterogeneous disease that has been investigated less extensively than invasive breast cancer. Women with DCIS are…”
Get full text

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer by Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fabbri, Francesco, Donati, Caterina, Nanni, Oriana, Fedeli, Anna, Faedi, Marina, Amadori, Dino

“…Purpose Combination of anthracyclines with trastuzumab is hampered by cardiotoxicity. Pegylated liposomal doxorubicin and lapatinib could represent a safer…”
Get full text

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer by Rocca, Andrea, Farolfi, Alberto, Maltoni, Roberta, Carretta, Elisa, Melegari, Elisabetta, Ferrario, Cristiano, Cecconetto, Lorenzo, Sarti, Samanta, Schirone, Alessio, Fedeli, Anna, Andreis, Daniele, Pietri, Elisabetta, Ibrahim, Toni, Montalto, Erika, Amadori, Dino

“…We assessed whether progesterone receptor (PgR) and Ki67 in primary tumors and/or matched metastases are predictors of clinical benefit from first-line…”
Get full text

A phase Ib study of lapatinib plus pegylated liposomal doxorubicin in patients with advanced HER2-positive breast cancer by Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fedeli, Anna, Donati, Caterina, Nanni, Oriana, Amadori, Dino

“…Abstract only…”
Get full text

Is androgen receptor useful to predict the efficacy of anti-estrogen therapy in advanced breast cancer? by Rocca, Andrea, Bronte, Giuseppe, Ravaioli, Sara, Puccetti, Maurizio, Tumedei, Maria Maddalena, Scarpi, Emanuela, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Bedei, Lucia, Fedeli, Anna, Andreis, Daniele, Pietri, Elisabetta, Calistri, Daniele, Amadori, Dino, Bravaccini, Sara

“…Abstract only 1042 Background: The androgen receptor (AR) is widely expressed in breast cancers but its role in estrogen receptor (ER)-positive tumors is still…”
Get full text

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma inￂ situ treated with surgery and radiotherapy by Ravaioli, Sara, Tumedei, Maria Maddalena, Foca, Flavia, Maltoni, Roberta, Rocca, Andrea, Massa, Ilaria, Pietri, Elisabetta, Bravaccini, Sara

“…Summary Ductal carcinoma in situ (DCIS) is a heterogeneous disease that has been investigated less extensively than invasive breast cancer. Women with DCIS are…”
Get full text

A Phase II Study of a Dose‐Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer by Pietri, Elisabetta, Andreis, Daniele, Fabbri, Francesca, Menna, Cecilia, Schirone, Alessio, Kopf, Barbara, Rocca, Andrea, Amadori, Dino, De Giorgi, Ugo

“…Background. Recent evidence shows that use of anthracycline and taxane adjuvant chemotherapy and dose‐dense regimens, consisting of more frequent…”
Get full text